Physician profile
Hamza Beano
NPI 1396150306
$9,696.57
in general payments reported to CMS, 2019-2025
51 companies · $2,032 in 2025
The $2,032 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $666 · 2021: $1,606 · 2022: $1,253 · 2023: $1,368 · 2024: $2,178 · 2025: $2,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,160 · Travel and Lodging: $1,250 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,160.49 |
| Travel and Lodging | $1,249.78 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,003.65 | 2019-2025 | Ams 700 |
| Agiliti Surgical, INC. | $1,294.88 | 2023-2024 | Sonablate Hifu, Trinity, Sonablate |
| Coloplast Corp | $1,282.24 | 2020-2025 | Titan |
| Astellas Pharma US INC | $508.26 | 2021-2025 | Myrbetriq, Xtandi, Veozah |
| Procept Biorobotics Corporation | $439.16 | 2022-2025 | Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $429.78 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $370.54 | 2021-2025 | Jelmyto |
| Olympus America INC. | $342.79 | 2023-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $282.65 | 2021-2025 | Provenge |
| Antares Pharma, INC. | $218.98 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Calyxo, INC. | $171.25 | 2024-2025 | Cvac Aspiration System |
| Innovation Technologies INC | $169.99 | 2023 | Irrisept |
| Rochester Medical Corporation | $147.33 | 2022 | |
| Myriad Genetic Laboratories, INC. | $138.59 | 2021-2024 | Prolaris |
| Endo USA, INC. | $134.57 | 2024-2025 | Xiaflex, Aveed |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamza Beano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.